GeneBio Systems
Anti-p16INK4a/CDKN2 Antibody (Monoclonal, DCS-50)
Anti-p16INK4a/CDKN2 Antibody (Monoclonal, DCS-50)
SKU:MA1074
Couldn't load pickup availability
Size: 100 μg
Storage: Store at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles.
Form: Lyophilized
Reactivity: Human
Applications: IHC,ICC,WB
Application Details: Immunocytochemistry , 1μg/ml, Human, -
Immunohistochemistry (Frozen Section), 1-2μg/ml, Human, -
Western blot, 0.5-1μg/ml, Human
Gene Name: CDKN2A
Specificity: No cross reactivity with other proteins.
Background: p16 (INK4A), also known as cyclin-dependent kinase inhibitor 2A (CDKN2A), or multiple tumor suppressor 1 (MTS1). The p16 gene (CDKN2A) was mapped to 9p21. The p16 gene encodes a negative regulator of the cell cycle. CDKN2 plays an important role during tumorigenesis or tumor progression in a significant proportion of pancreatic adenocarcinomas. Germ-line mutations in the CDKN2A tumor-suppressor gene have been linked to the development of melanoma in some families with inherited melanoma.
Immunogen: Recombinant human p16 protein.
Clonality: Monoclonal
Contents: Mouse IgG in stabilizing components, 1.2% sodium acetate and 0.01mg NaN3.
*This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.
Purification: Ascites
Reconstitution: Add 1ml of PBS buffer will yield a concentration of 100ug/ml.
Reference: 1. Stone, S.; Jiang, P.; Dayananth, P.; Tavtigian, S. W.; Katcher, H.; Parry, D.; Peters, G.; Kamb, A. : Complex structure and regulation of the p16(MTS1) locus. Cancer Res. 55: 2988-2994, 1995. 2. Monzon, J.; Liu, L.; Brill, H.; Goldstein, A. M.; Tucker, M. A.; From, L.; McLaughlin, J.; Hogg, D.; Lassam, N. J. : CDKN2A mutations in multiple primary melanomas. New Eng. J. Med. 338: 879-887, 1998. 3. Bartsch, D.; Shevlin, D. W.; Tung, W. S.; Kisker, O.; Wells, S. A., Jr.; Goodfellow, P. J. : Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes Cancer 14: 189-195, 1995
Uniprot ID: Q9R0Z3
Host: Mouse
Concentration: Adding 1 ml of PBS buffer will yield a concentration of 100 μg/ml.
Conjugate:
Cross Reactivity: No cross-reactivity with other proteins
Isotype: Mouse IgG1
Phospho_site:
Clone Number: Clone: DCS-50
Observed Molecular Weight: 200 kDa
Calculated Molecular Weight: 17366 MW
Gene ID: Human(1029), Mouse(12578), Rat(25163 )
Protein Name: Cyclin-dependent kinase inhibitor 2A
Gene Full Name: cyclin-dependent kinase inhibitor 2A
Synonyms: ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A; CDK4 INHIBITOR; cyclin-dependent kinase inhibitor 2A(melanoma, p16, inhibits CDK4); Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1; Collaborator of ARF
